DOI: 10.36347/sasjs.2021.v07i03.010

Pages: 150-154

Aim: To review the epidemiological and clinical features, management, and outcomes of surgical treatment of eyelid squamous cell carcinoma. Methods: A retrospective review of all eyelid squamous cell carcinoma treated between 2012 and 2019. Results: 21 cases were identified in 21 patients. Patient ages ranged from 7 to 70 years, with a mean age of 56 years. 14 patients were male and 7 were female. The lower eyelid was the site of origin for 13 tumors. Lesion size ranged from 2 mm to 36 mm with a median of 6 mm. Orbital invasion was found in two patients. No patients developed lymph node or distant metastases. Treatment was by complete excision with histological confirmation of clear margins. Exenteration was required in two patients. Mean follow up was 28 months. During the follow-up period, there was no recurrence or death reported. Conclusions: Eyelid squamous cell carcinoma is a relatively uncommon, but potentially fatal disease by orbital invasion or metastasis. However, if detected early and treated adequately, the prognosis is generally excellent.